A medical device dry-eye treatment that wants to replace eye drops has received U.S. Food and Drug Administration approval. North Carolina’s TearScience has won FDA approval for its LipiFlow Thermal ...

1. The LipiFlow is designed to treat dry eye, meibomian gland dysfunction and other eyelid complications. 2. The FDA-approved device removes gland blockages and restores their function. 3. LipiFlow ...

North Carolina-based TearScience today announced the FDA approval of its LipiFlow thermal pulsation system for treating meibomian gland disease. This device is designed to apply heat to the inside of ...

MORRISVILLE, N.C.--(BUSINESS WIRE)--TearScience, Inc., a privately-held medical device company, today announced that it has received U.S. Food and Drug Administration (FDA) clearance for its next ...

NEW YORK (CBSNewYork) - A breakthrough device may provide some much-needed relief for the estimated 25 million Americans who suffer from dry eyes. Dry eye sufferers often feel like they have something ...

TearScience will tap up to a whopping $70 million in new financing to ramp up commercial marketing efforts for its dry eye treatment device. HealthCare Royalty Partners is the sole backer of the new ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. NEW YORK — LipiFlow single-use activators will soon cost ...

SANTA ANA, Calif., July 24, 2021 /PRNewswire/ -- Johnson & Johnson Vision*, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies**, today revealed new comparative ...

MORRISVILLE, N.C., May 4, 2017 /PRNewswire/ -- TearScience, a privately held medical device company and manufacturer of LipiFlow ® for treatment of meibomian gland dysfunction (MGD), announced today ...

Dry eye treatment company TearScience, which is considering plans for an initial public stock offering, now has a new chief financial officer. The medical device company has promoted Nicole Wicker ...

A Cure for Dry Eye? Group practices and outpatient centers specializing in eye care, including some associated with laser surgery and others focusing on contact lenses, have been the early adopters of ...

Dry eye treatment company TearScience, which is considering plans for an initial public stock offering, now has a new chief financial officer. The medical device company has promoted Nicole Wicker ...